Matrix Laboratories (Delisted) bulk deals and stake changes

BSE: 524794

Last traded ₹209.35 on 13 Aug 2009

Delisted on 21 Aug 2009.

Matrix Laboratories stake sales and purchases

All 14 disclosures on record.

  1. Jul 2009

    • AcquiredMP Laboratories (M) Ltd1.72% of the company26,88,312 sharesholds 89.45% after30 Jul 2009 · filed under the 1997 takeover rules · Delisting Offer
    • AcquiredMP Laboratories (M) Ltd0.05% of the company78,430 sharesholds 87.73% after14 Jul 2009 · filed under the 1997 takeover rules · Delisting Offer
  2. Jun 2009

    • AcquiredMP Laboratories (M) Ltd17.50% of the company2,70,53,416 sharesholds 88.66% after3 Jun 2009 · filed under the 1997 takeover rules · Delisting Offer
    • SoldHSBC Global Inv Funds & PAC7.18% of the company1,11,00,000 shares3 Jun 2009 · filed under the 1997 takeover rules · Delisting Offer
    • AcquiredMP Laboratories (Mauritius) Ltd17.50% of the company2,70,53,416 sharesholds 88.66% after3 Jun 2009 · filed under the 1997 takeover rules · Delisting Offer
  3. Aug 2008

    • AcquiredHSBC GLOBAL INV FUNDS (M) LTD & PAC0.03% of the company50,000 sharesholds 7.07% after28 Aug 2008
  4. Oct 2007

    • AcquiredHSBC GLOBAL INV FUNDS (M) LTD & PAC0.09% of the company1,41,000 sharesholds 5.06% after12 Oct 2007
    • AcquiredHSBC INVESTMENTS (SINGAPORE) LTD & PAC1,41,000 sharesholds 5.06% after12 Oct 2007
  5. Feb 2007

    • AcquiredMERRILL LYNCH CAPT MKT ESPANA S.A.S.V & PAC0.77% of the company11,84,024 sharesholds 5.43% after14 Feb 2007
    • AcquiredMERRILL LYNCH CAPITAL MARKETS ESPANA SA SV0.77% of the company11,84,024 sharesholds 5.43% after14 Feb 2007
  6. Jan 2007

    • AcquiredMP LABS (MAURITIUS) LTD&MYLAN LABS. INC.20.03% of the company3,08,31,962 sharesholds 71.46% after18 Jan 2007
    • SoldG2 CORPORATE SERVICE LTD6.50% of the company1,00,00,000 shares8 Jan 2007
    • SoldN PRASAD5.19% of the company79,92,192 sharesholds 4.99% after8 Jan 2007
    • SoldN PRASAD HUF0.39% of the company6,00,000 shares8 Jan 2007

The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.

Matrix Laboratories bulk deals

ValuePer cent of the company

Monday 10 Nov 20081 firm · ₹19 Cr bought · ₹0 soldNet bought ₹19 Cr
  • BoughtSWISS FINANCE CORP MAU LTDBought 21,40,000 at ₹88.501.38% of the company₹19 Cr

A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. 1 deal on record from 4 Jan 2004.